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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
 
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
28.05.2020 Description of 
COVID-19 in 
HIV-infected 
individuals: a 
single-centre, 
prospective 
cohort 
The Lancet HIV 
| Article 
 This observational prospective 
study characterises individuals 
aged >=18y with COVID-19 
among a cohort of HIV-infected 
adults in Madrid. Included as 
information about incidence, 
clinical characteristics and 
outcomes of HIV-infected 
individuals with SARS-CoV-2 
infection is scarce 
 As of 30 April 2020, 51 COVID-19 
cases were diagnosed among a 
cohort of 2873 HIV-infected 
individuals 
 COVID-19 presented similar 
clinical, laboratory and radiological 
features in HIV-infected individuals 
compared with reports of the 
general population 
 Among HIV-infected individuals, 
lower CD4 cell counts affected 
disease severity and viral kinetics 
suggesting that those with low 
CD4 cell counts might have worse 
2 
outcomes than individuals with 
restored immunity 
 HIV-infected individuals should 
receive the same treatment 
approach applied to the general 
population 
28.05.2020 COVID-19 
mortality in 
patients with 
cancer on 
chemotherapy or 
other anticancer 
treatments: a 
prospective 
cohort study 
The Lancet | 
Article 
 This prospective observational 
study in the UK describes the 
clinical and demographic 
characterises and C19 outcomes 
in patients with cancer. Included 
as data from large multicentre 
studies to support the assumption 
that individuals with cancer are at 
increased risk of mortality from 
C19 are scarce 
 Authors did not identify evidence 
that cancer patients on cytotoxic 
chemotherapy or other anti-cancer 
treatments are at increased risk of 
mortality from C19, compared to 
those not on active treatment 
 Mortality from COVID-19 in cancer 
patients appears to be driven by 
age, sex and co-morbidities 
28.05.2020 Clinical impact of 
COVID-19 on 
patients with 
cancer (CCC19): 
a cohort study 
The Lancet | 
Article 
 This study characterises outcomes 
of a cohort of 928 patients aged 
>=18y with cancer and COVID-19 
from the USA, Canada and Spain 
from the COVID-19 and Cancer 
Consortium (CCC19) database 
diverse in terms of age 
distribution, race and ethnicity, 
cancer status, and whether on 
anticancer treatment. Included as 
data on patients with COVID-19 
who have cancer are lacking 
 Among patients with cancer and 
COVID-19, 30-day all-cause 
mortality was high and associated 
with general risk factors and risk 
factors unique to patients with 
cancer 
  
3 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
30.05.2020 COVID-19 in Africa: no room for 
complacency 
The Lancet | Editorial   
30.05.2020 Fears of “highly catastrophic” 
COVID-19 spread in Yemen 
The Lancet | World 
Report 
Sharmila Devi 
29.05.2020 Covid-19 study on 
hydroxychloroquine use 
questioned by 120 researchers and 
medical professionals 
The Guardian | News Melissa Davey 
29.05.2020 COVID-19 research in Africa Science | Editorial Linda-Gail Bekker 
Valerie Mizrahi 
29.05.2020 Paying participants in COVID-19 
trials 
The Journal of 
Infectious Diseases | 
Review 
Emily A. Largent 
Holly Fernandez 
Lynch 
28.05.2020 The starting line for COVID-19 
vaccine development 
The Lancet | 
Comment 
Nelson Lee 
Allison McGeer 
28.05.2020 COVID-19 in people with HIV The Lancet HIV | 
Comment 
Zhe Xu 
Chao Zhang 
Fu-Sheng Wang 
27.05.2020 A voice from the front line: reaching 
out of the box to engage private 
non-state healthcare actors in 
LMICs to combat COVID-19 
Health Policy and 
Planning | Blog 
Priya 
Balasubramaniam 
et al. 
May 2020 First measles, now COVID-19 – are 
outbreaks finally moving the dial on 
vaccine hesitancy? 
LSHTM | Feature Jacqui Thornton 
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Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including trials 
  Diagnosti
cs 
  Treatment
s 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-
CoV-2 
Diagnostic
s: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based 
tests for 
COVID-19 
  Solidarity 
trial 
 COVID-
19 
Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: 
C19 
Testing 
  COVID-
19 
Therapeuti
cs 
Accelerator 
  
Our World 
in Data 
  Singapor
e 
 Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 
5050 
  UK  IFPRI 
COVID-19 
Policy 
Cochrane       
5 
Response 
Portal 
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
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HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Region
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Country 
Academi
c journals 
& 
Publisher
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Institutes/Centres/Funders/O
ther 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa 
CDC 
Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
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n 
African 
Union 
BMJ LSHTM 
 
  IDA 
6 
WHO Q&A Nigeria 
CDC 
Bulletin 
of the 
WHO 
ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll
: SSA 
Cambridg
e 
Universit
y Press 
ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academ
y of 
Science
s 
Cochrane  Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidenc
e 
Network 
Elsevier CMMID Repository     
UNOCHA OCHA 
Souther
n and 
Eastern 
Africa 
COVID-
19 
Digest 
JAMA 
Network 
Norwegian Institute of Public 
Health 
    
UNHCR   The 
Lancet 
Oxford Centre for Evidence-
based Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints
) 
 HEART     
7 
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
Universit
y Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources and 
Analyses of C19 Impact 
    
World Bank   Science  Prevent Epidemics      
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David 
Nabarro 
  SSRN 
(Preprints
)  
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OpenStreetM
ap Team 
          
Global 
Partnership 
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Development 
Data 
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Flowminder           
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Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
May 28 
09:30 am to 
11:00 am 
EDT 
Virtual Event - No 
backsliding: How can 
we re-orient food 
systems and health 
systems to protect 
nutrition and healthy 
diets in the context of 
COVID-19? 
Virtual event 1.5 hours IFPRI 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
04.06.2020 
12pm ET 
CGD Conversations 
on COVID-19 and 
Development: John 
Nkengasong 
Event   CGD 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
9 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
10 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
